- Home
- SGBX vs PULM Comparison
SGBX vs PULM Comparison
Compare SGBX & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGBX | PULM |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1M | 18.3M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGBX | PULM |
|---|---|---|
| Price | $4.00 | $4.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 18.7M | 5.3K |
| Earning Date | 11-14-2025 | 10-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,382,896.00 | $3,000.00 |
| Revenue This Year | $1,628.82 | N/A |
| Revenue Next Year | N/A | $134.88 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.81 | $4.26 |
| 52 Week High | $122.88 | $10.40 |
Technical Indicators
Market Signals| Indicator | SGBX | PULM |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 38.05 |
| Support Level | $2.91 | $4.32 |
| Resistance Level | $4.04 | $4.67 |
| Average True Range (ATR) | 1.40 | 0.29 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 26.04 | 0.03 |
Price Performance
Historical ComparisonAbout SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).